Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Vigil Neuroscience is a biotech company developing microglia-targeted, disease-modifying therapeutics for neurodegenerative diseases. Its pipeline includes monoclonal antibodies and small molecules aimed at activating TREM2, a key microglial receptor. Focused on rare conditions like ALSP and common diseases such as Alzheimer's, Vigil leverages precision medicine, biomarkers, and stakeholder engagement to address unmet medical needs in CNS health.
This description was generated via AI from an annual report. Updated about 1 year ago.